Byers Eye Institute at Stanford
Palo Alto, California, 94303, United States
NCT Number: NCT01592643
The purpose of this research is to determine if an investigational thin shield over the cornea can safely and effectively reduce or eliminate pain following Post Photorefractive Keratectomy (PRK).
The thin shield is made of silicone. The materials used to make the corneal shield all have a history of use in medical devices, contact lenses, and/or corneal shields and have been used safely in the eye.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Palo Alto, California, 94303, United States
See above
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
.
Exclusion criteria
.
The thin shield is made of silicone. The materials used to make the corneal shield all have a history of use in medical devices, contact lenses, and/or corneal shields and have been used safely in the eye.
Other names: Nexis Vision corneal shield
Time frame: Day 30
Time frame: Six months
LogMAR uncorrected visual acuity. Values closer to zero indicate improved vision
Stanford University
Other
Acronym: Nexis-CS0032
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02699697
Malignant Neoplasm, Metastatic Malignant Neoplasm in the Bone
Winston-Salem, North Carolina, United States
View Trial DetailsNCT07738718
Dental Anxiety, Neurologic Manifestations
Ar Rass, Al-Qassim Region, Saudi Arabia
View Trial DetailsNCT07776860
Fear, Neurologic Manifestations
Izmir, Menemen, Turkey (Türkiye)
View Trial DetailsNCT07777432
Agnosia, Behavior
Vinaròs, Castellón, Spain
View Trial Details